Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PD146176
Cat. No.:
OB0225LY-0466
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
PD146176 is a compound that selectively inhibits MEK1/2 and is primarily used to study cellular signaling pathways.
Synonym:
NSC168807; 4079-26-9; PD-146176; 6,11-Dihydro[1]benzothiopyrano[4,3-b]indole; 6,11-Dihydro-5-thia-11-aza-benzo(a)fluorene; (1)Benzothiopyrano(4,3-b)indole, 6,11-dihydro-
CAS No.:
4079-26-9
Compound CID:
297589
Formula:
C15H11NS
Formula Weight:
237.32
Specification
Relative Density:
1.333 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
PD146176 can be used to study the mechanisms of tumor cell proliferation and metastasis, or play an important role in signal transduction-related disease models.
Library Information
Targets:
Lipoxygenase
Receptors:
15-LO
Pathways:
Autophagy; Apoptosis; Metabolism
Plate Number:
AOCL-7
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
25 mg/mL; 105.34 mM
Water Max Solubility:
<0.1 mg/mL (insoluble)
